Efficacy of chlorhexidine bathing for reducing healthcare associated bloodstream infections: a meta-analysis

Annals of Intensive Care

Volumn 5, Issue 1, 2015, Pages

  Choi, Eun Young ^a   Park, Dong Ah ^b   Kim, Hyun Jung ^c,d   Park, Jinkyeong ^e  

^a Yeungnam University College of Medicine   (South Korea)

^b National Evidence Based Healthcare Collaborating Agency   (South Korea)

^c Institute for Evidence based Medicine The Korean Branch of Australasian Cochrane Center   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Chlorhexidine; Critically ill; Meta analysis; MRSA; Mupirocin

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ARTICLE; BACTERIUM ISOLATION; BATH; BLOODSTREAM INFECTION; CRITICALLY ILL PATIENT; DRUG EFFICACY; GENETIC HETEROGENEITY; HEALTH CARE; HOSPITAL INFECTION; HUMAN; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84943237312     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-015-0073-9     Document Type: Article

References (27)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21(8):510–5. doi:10.1086/501795.
2. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368(9538):874–85.
3. Kreman T, Hu J, Pottinger J, Herwaldt LA. Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2005;26(10):811–5. doi:10.1086/502498.
4. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164. doi:10.1016/j.ajic.2007.10.007.
5. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776–82. doi:10.1086/422997.
6. Weinstein RA, Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis. 2008;46(2):274–81. doi:10.1086/524736.
7. Derde LP, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14(1):31–9. doi:10.1016/s1473-3099(13)70295-0.
8. Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV, Cuschieri J. EFfect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg. 2010;145(3):240–6. doi:10.1001/archsurg.2010.5.
9. Dixon JM, Carver RL. Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections. Am J Infect Control. 2010;38(10):817–21.
10. Montecalvo MA, McKenna D, Yarrish R, Mack L, Maguire G, Haas J, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med. 2012;125(5):505–11.
11. O’Horo JC, Silva GLM, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol. 2012;33(3):257–67.
12. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368(6):533–42.
13. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. Targeted versus universal decolonization to prevent ICU infection. N Eng J Med. 2013;368(24):2255–65. doi:10.1056/NEJMoa1207290.
14. Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA. 2015;313(4):369–78. doi:10.1001/jama.2014.18400.
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
16. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
18. Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
19. Harris R, Bradburn M, Deeks J, Harbord R, Altman D, Sterne J. Metan: fixed- and random-effects meta-analysis. Stata J. 2008;8(1):3–28.
20. Popovich KJ, Lyles R, Hayes R, Hota B, Trick W, Weinstein RA, et al. Relation of chlorhexidine gluconate skin concentration to microbial density on skin of critically ill patients bathed daily with chlorhexidine gluconate. Infect Control Hosp Epidemiol. 2012;33(9):889.
21. Sangal V, Girvan EK, Jadhav S, Lawes T, Robb A, Vali L, et al. Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit in Scotland. Int J Antimicrob Agents. 2012;40(4):323–31.
22. Mendoza-Olazarán S, Camacho-Ortiz A, Martínez-Reséndez MF, Llaca-Díaz JM, Pérez-Rodríguez E, Garza-González E. Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates. Am J Infect Control. 2014;42(8):874–8. doi:10.1016/j.ajic.2014.04.009.
23. Camus C, Bellissant E, Sebille V, Perrotin D, Garo B, Legras A, et al. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med. 2005;33(2):307–14.
24. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med. 2007;167(19):2073–9.
25. Camus C, Sebille V, Legras A, Garo B, Renault A, Le Corre P, et al. Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients. Infection. 2014;42(3):493–502. doi:10.1007/s15010-013-0581-1.
26. Derde LP, Dautzenberg MJ, Bonten MJ. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensiv Care Med. 2012;38(6):931–9. doi:10.1007/s00134-012-2542-z.
27. Pittet D, Angus DC. Daily chlorhexidine bathing for critically ill patients: a note of caution. JAMA. 2015;313(4):365–6. doi:10.1001/jama.2014.18482.